Astellas Network Meta-Analysis Compares Zolbetuximab With ICI Regimens Across PD-L1 Subgroups in Advanced Gastric Cancer
Sep 18, 2026
View online
Astellas Network Meta-Analysis Compares Zolbetuximab With ICI Regimens Across PD-L1 Subgroups in Advanced Gastric Cancer
FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer
WHO Opens First-Ever Prequalification Pathway for 12 Childhood Cancer Medicines
OpenAI Foundation Awards $40M to UNC Lineberger to Advance Personalized Cancer Vaccines
Nicholas Hornstein: Fecal Microbiota Transplant Achieves Responses in Patients With ICI Colitis
Carlos Rodriguez-Galindo։ New Market Shaping Strategy for Childhood Cancer Medicines Launched
Enrique Soto Perez de Celis: Cancer Is Increasingly a Disease of Aging, but Policies Are Not Keeping Pace
GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg
CRI Clinic and Laboratory Integration Program 2027
CRI Technology Impact Award 2026–2027
The Global Health Catalyst Summit 2026
Florida Society of Clinical Oncology Breaking Barriers Summit
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
